Clinical Trial Update: Effect of Anti-TNF (Alpha) Treatment on Vascular Stiffness in Ankylosing Spondylitis (AS) [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating anti-TNF alpha therapy on vascular stiffness in ankylosing spondylitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ankylosing Spondylitis

Drugs mentioned

• Anti-TNF-alpha therapy

Snippet

Sponsor: Chinese University of Hong Kong | Conditions: Ankylosing Spondylitis(AS) | Phase 4 | Status: COMPLETED